Roivant Sciences plugs away at IPO market

摘要

Few biotech sponsors are as controversial as Roivant Sciences, the investment vehicle of former hedge fund manager Vivek Ramaswamy. All three Roivant-backed IPOs that have gone public, Axovant Sciences, Myovant Sciences and Urovant Sciences are all trading well below their original offering prices.